At the news
? NEUTRALIMPACT 2/10 DEFA14A filed Nov 6, 2026 at 17:02 ET
Ocugen, Inc. filed a DEFA14A (additional definitive proxy soliciting materials) on November 6, 2026. The filing contains no substantive proxy content beyond the form type and metadata; the document text is limited to boilerplate SEC form headers and graphic images. No specific shareholder vote, activist campaign, or merger proposal is described.
- Form DEFA14A filed by Ocugen, Inc. on 2026-11-06
- Filed by the registrant (management)
- No substantive proxy content in the filing text
- Market cap $297M, normal daily move 4.9%
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access